PREOPERATIVE PREDICTIVE FACTORS AND FURTHER RISK STRATIFICATION OF BIOCHEMICAL RECURRENCE IN CLINICALLY LOCALIZED HIGH RISK PROSTATE CANCER

被引：0
|
作者：
Hamada, Riu
Nakashima, Jun
Hashimoto, Takeshi
Satake, Naoya
Nakagami, Yoshihiro
Ozu, Choichiro
Ohno, Yoshio
Horiguchi, Yutaka
Namiki, Kazunori
Yoshioka, Kunihiko
Ohori, Makoto
Tachibana, Masaaki
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词：
D O I：
10.1016/j.juro.2013.02.585
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1001
引用
收藏
页码：E411 / E411
页数：1
相关论文
共 50 条
  • [41] Genomics and risk stratification in high-risk prostate cancer
    Bashir Al Hussein Al Awamlh
    Jonathan E. Shoag
    [J]. Nature Reviews Urology, 2019, 16 : 641 - 642
  • [42] Genomics and risk stratification in high-risk prostate cancer
    Al Awamlh, Bashir Al Hussein
    Shoag, Jonathan E.
    [J]. NATURE REVIEWS UROLOGY, 2019, 16 (11) : 641 - 642
  • [43] Risk of progression and dying of clinically localized prostate cancer in Japan
    Egawa, S
    Satoh, T
    Suyama, K
    Iwamura, M
    Uchida, T
    Koshiba, K
    [J]. WORLD JOURNAL OF UROLOGY, 1996, 14 (06) : 363 - 369
  • [44] Preoperative Predictors of Biochemical Recurrence-Free Survival in High-Risk Prostate Cancer Following Radical Prostatectomy
    Nkengurutse, Gerard
    Tian, Feng
    Jiang, Sixiong
    Wang, Qi
    Wang, Ying
    Sun, Weibing
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [45] A PREOPERATIVE SERUM BIOMARKER PANEL TO IDENTIFY PATIENTS WITH PROSTATE CANCER AT HIGH RISK OF BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY
    Oon, S. F.
    Fan, Y.
    Fitzpatrick, J. M.
    Klocker, H.
    Watson, R. W. G.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 237 - 237
  • [46] ERG Immunoexpression Does Not Predict Risk of Recurrence after Prostatectomy for Clinically-Localized Prostate Cancer
    Gonzalez-Roibon, N. D.
    Peskoe, S.
    Chaux, A.
    Albadine, R.
    Hicks, J.
    De Marzo, A.
    Platz, E. A.
    Netto, G. J.
    [J]. MODERN PATHOLOGY, 2012, 25 : 209A - 209A
  • [47] ERG Immunoexpression Does Not Predict Risk of Recurrence after Prostatectomy for Clinically-Localized Prostate Cancer
    Gonzalez-Roibon, N. D.
    Peskoe, S.
    Chaux, A.
    Albadine, R.
    Hicks, J.
    De Marzo, A.
    Platz, E. A.
    Netto, G. J.
    [J]. LABORATORY INVESTIGATION, 2012, 92 : 209A - 209A
  • [48] Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer
    Chaux, Alcides
    Peskoe, Sarah B.
    Gonzalez-Roibon, Nilda
    Schultz, Luciana
    Albadine, Roula
    Hicks, Jessica
    De Marzo, Angelo M.
    Platz, Elizabeth A.
    Netto, George J.
    [J]. MODERN PATHOLOGY, 2012, 25 (11) : 1543 - 1549
  • [49] Surgical Delay and Pathological Outcomes for Clinically Localized High-Risk Prostate Cancer
    Xia, Leilei
    Talwar, Ruchika
    Chelluri, Raju R.
    Guzzo, Thomas J.
    Lee, Daniel J.
    [J]. JAMA NETWORK OPEN, 2020, 3 (12) : E2028320
  • [50] RADIOTHERAPY AND ANDROGEN ABLATION FOR CLINICALLY LOCALIZED HIGH-RISK PROSTATE-CANCER
    POLLACK, A
    ZAGARS, GK
    KOPPLIN, S
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (01): : 13 - 20
12345